193 related articles for article (PubMed ID: 6691743)
1. Subclavian-pulmonary artery shunts with polytetrafluorethylene interposition grafts.
Bove EL; Sondheimer HM; Kavey RE; Byrum CJ; Blackman MS; Parker FB
Ann Thorac Surg; 1984 Jan; 37(1):88-91. PubMed ID: 6691743
[TBL] [Abstract][Full Text] [Related]
2. Systemic-pulmonary shunts in infants and children. Early and late results.
Lamberti JJ; Carlisle J; Waldman JD; Lodge FA; Kirkpatrick SE; George L; Mathewson JW; Turner SW; Pappelbaum SJ
J Thorac Cardiovasc Surg; 1984 Jul; 88(1):76-81. PubMed ID: 6204171
[TBL] [Abstract][Full Text] [Related]
3. The modified blalock-taussig shunt using microporous expanded polytetrafluoroethylene (PTFE).
Lawless CE; Smith EE; Hallidie-Smith K; Sapsford RN
J Cardiovasc Surg (Torino); 1982; 23(4):287-92. PubMed ID: 7107686
[TBL] [Abstract][Full Text] [Related]
4. Blalock-Taussig shunts and modified Blalock-Taussig shunts.
Sanchez HE; Vosloo S
S Afr Med J; 1985 Feb; 67(5):168-70. PubMed ID: 3983755
[TBL] [Abstract][Full Text] [Related]
5. Experience with the modified Blalock-Taussig operation using polytetrafluoroethylene (Impra) grafts.
Kay PH; Capuani A; Franks R; Lincoln C
Br Heart J; 1983 Apr; 49(4):359-63. PubMed ID: 6830670
[TBL] [Abstract][Full Text] [Related]
6. The Blalock-Taussig shunt in infants: standard versus modified.
Ullom RL; Sade RM; Crawford FA; Ross BA; Spinale F
Ann Thorac Surg; 1987 Nov; 44(5):539-43. PubMed ID: 3675059
[TBL] [Abstract][Full Text] [Related]
7. Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts.
de Leval MR; McKay R; Jones M; Stark J; Macartney FJ
J Thorac Cardiovasc Surg; 1981 Jan; 81(1):112-9. PubMed ID: 6450303
[TBL] [Abstract][Full Text] [Related]
8. Progress of patients with pulmonary atresia after systemic to pulmonary arterial shunts.
Calder AL; Chan NS; Clarkson PM; Kerr AR; Neutze JM
Ann Thorac Surg; 1991 Mar; 51(3):401-7. PubMed ID: 1705418
[TBL] [Abstract][Full Text] [Related]
9. Classic versus modified Blalock-Taussig shunts in neonates and infants.
Moulton AL; Brenner JI; Ringel R; Nordenberg A; Berman MA; Ali S; Burns J
Circulation; 1985 Sep; 72(3 Pt 2):II35-44. PubMed ID: 4028366
[TBL] [Abstract][Full Text] [Related]
10. A comparison of Blalock-Taussig, Waterston, and polytetrafluoroethylene shunts in children less than two weeks of age.
Woolf PK; Stephenson LW; Meijboom E; Bavinck JH; Gardner TJ; Donahoo JS; Edie RN; Edmunds LH
Ann Thorac Surg; 1984 Jul; 38(1):26-30. PubMed ID: 6203495
[TBL] [Abstract][Full Text] [Related]
11. A five-year clinical experience with 112 Blalock-Taussig shunts.
Gold JP; Violaris K; Engle MA; Klein AA; Ehlers KH; Lang SJ; Levin AR; Moran F; O'Loughlin JE; Snyder MS
J Card Surg; 1993 Jan; 8(1):9-17. PubMed ID: 8422496
[TBL] [Abstract][Full Text] [Related]
12. Systemic-Pulmonary shunts inneonates and infants using microporous expanded polytetrafluoroethylene: immediate and late results.
Donahoo JS; Gardner TJ; Zahka K; Kidd BS
Ann Thorac Surg; 1980 Aug; 30(2):146-50. PubMed ID: 7416837
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary hemodynamics and maintenance of palliation following polytetrafluoroethylene shunts for cyanotic congenital heart disease.
Bove EL; Sondheimer HM; Byrum CJ; Kavey RE; Blackman MS
Am Heart J; 1984 Aug; 108(2):366-9. PubMed ID: 6205578
[TBL] [Abstract][Full Text] [Related]
14. Systemic-pulmonary polytetrafluoroethylene shunts in palliative operations for congenital heart disease. Revival of the central shunt.
Amato JJ; Marbey ML; Bush C; Galdieri RJ; Cotroneo JV; Bushong J
J Thorac Cardiovasc Surg; 1988 Jan; 95(1):62-9. PubMed ID: 2447447
[TBL] [Abstract][Full Text] [Related]
15. Polytetrafluoroethylene shunts in congenital heart disease.
Nanton MA; Roy DL; Murphy DM; Finley JP; Lau H; Gillis DA; Murphy DA
Can J Surg; 1982 Mar; 25(2):134-8. PubMed ID: 7066772
[TBL] [Abstract][Full Text] [Related]
16. Modified Blalock-Taussig shunt in newborn infants.
Ilbawi MN; Grieco J; DeLeon SY; Idriss FS; Muster AJ; Berry TE; Klich J
J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 1):770-5. PubMed ID: 6492843
[TBL] [Abstract][Full Text] [Related]
17. Experience with PTFE-prostheses for construction of Blalock-Taussig shunts.
Rigler B; Metzler H; Beitzke A; Stenzl W; Rehak P; Kraft-Kinz J
Life Support Syst; 1983; 1 Suppl 1():394-5. PubMed ID: 6086034
[No Abstract] [Full Text] [Related]
18. Modified Blalock-Taussig shunt in infants and young children. Clinical and catheterization assessment.
Karpawich PP; Bush CP; Antillon JR; Amato JJ; Marbey ML; Agarwal KC
J Thorac Cardiovasc Surg; 1985 Feb; 89(2):275-9. PubMed ID: 3968910
[TBL] [Abstract][Full Text] [Related]
19. Central aorta-pulmonary artery shunts in neonates with complex cyanotic congenital heart disease.
Barragry TP; Ring WS; Blatchford JW; Foker JE
J Thorac Cardiovasc Surg; 1987 May; 93(5):767-74. PubMed ID: 3573789
[TBL] [Abstract][Full Text] [Related]
20. The Blalock-Taussig shunt. Low risk, effective palliation, and pulmonary artery growth.
Guyton RA; Owens JE; Waumett JD; Dooley KJ; Hatcher CR; Williams WH
J Thorac Cardiovasc Surg; 1983 Jun; 85(6):917-22. PubMed ID: 6190047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
